Clinical Trials Logo

Pleural Effusion, Malignant clinical trials

View clinical trials related to Pleural Effusion, Malignant.

Filter by:

NCT ID: NCT01997190 Completed - Breast Cancer Clinical Trials

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

MpeTK01
Start date: October 2013
Phase: Phase 1
Study type: Interventional

This is a phase I study of intrapleural AdV-tk therapy in patients with malignant pleural effusion (MPE). The primary objective is to test the safety of intrapleural AdV-tk therapy. Secondary objectives are to evaluate clinical efficacy and biologic activity

NCT ID: NCT01670786 Completed - Clinical trials for Pleural Effusion, Malignant

Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion

Start date: January 2010
Phase: Phase 4
Study type: Interventional

Iodopovidone is safe when using as a pleurodesis sclerosing agent for malignant pleural effusion, with minimal adverse events, especially reducing dose.

NCT ID: NCT01661790 Completed - Clinical trials for Malignant Pleural Effusion

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Start date: August 2009
Phase: Phase 3
Study type: Interventional

To determine the efficacy and Safety of intrapleural Bevacizumab and cisplatin as a treatment for malignant pleural effusions (MPE) in patients with non-small cell lung cancer (NSCLC).

NCT ID: NCT01409551 Completed - Cost Effectiveness Clinical Trials

Video-assisted Hyperthermic Pleural Chemoperfusion vs Talc Pleurodesis for Refractory Malignant Pleural Effusions.

Start date: August 2011
Phase: N/A
Study type: Interventional

Aim of this study is to compare two methods of pleurodesis for refractory malignant pleural effusions, in terms of safety and efficacy.

NCT ID: NCT01327235 Completed - Clinical trials for Malignant Pleural Effusion

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Start date: March 2011
Phase: Phase 2
Study type: Interventional

The objective of this study is to compare the efficacy of Endostar/cisplatin with cisplatin alone or Endostar alone in patients with malignant pleural effusion or ascites.

NCT ID: NCT01256801 Completed - Breast Neoplasms Clinical Trials

Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion

GMPE
Start date: November 2010
Phase: Phase 3
Study type: Observational

The investigators want to develop a gene expression profile for the prediction of immunotherapy response of patients with metastatic breast cancer presenting malignant pleural effusion.

NCT ID: NCT01117740 Completed - Lung Cancer Clinical Trials

Pleural Catheters Versus Thoracoscopic Pleurodesis

Start date: April 2010
Phase: N/A
Study type: Observational

The goal of this clinical research study is to compare 2 different methods for treating a pleural effusion. Researchers also want to learn how the treatment you receive effects your quality of life (your ability to do the things you like to do and how happy you feel.

NCT ID: NCT00978939 Completed - Clinical trials for Pleural Effusion, Malignant

Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter

ASAP
Start date: August 2009
Phase: Phase 4
Study type: Interventional

Purpose and Objective: The purpose of this study is to determine if the rate of spontaneous pleurodesis using the Pleurx® catheter could be increased by simply increasing the frequency of pleural drainage and, if so, whether catheter-related complications can be minimized and spare patients the need for long term management of the Pleurx® catheter.

NCT ID: NCT00896285 Completed - Pleural Effusion Clinical Trials

The First Therapeutic Intervention in Malignant Pleural Effusion Trial

TIME-1
Start date: April 2009
Phase: N/A
Study type: Interventional

Fluid caused by cancer cells may accumulate in the lining of the lung. Draining the fluid with a chest tube may relieve pain and shortness of breath. To stop the fluid from coming back again, patients are given a medicine (talc) into the chest drain to seal up the space around the lung. This procedure is known as pleurodesis. This sometimes causes pain and discomfort, and the investigators do not know the best way of preventing this. The investigators hope to find the best way to prevent pain during pleurodesis.

NCT ID: NCT00789087 Completed - Clinical trials for Recurrent Malignant Pleural Effusion.

Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion

Start date: January 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to analyze and compare radiological lung expansion after talc pleurodesis performed either by videothoracoscopy or chest tube and correlate it with clinical outcome. Secondary endpoints evaluated were: clinical efficacy, safety, quality of life and survival.